TABLE 5.
Proportion of each indication in each of the two most recent SAGE surveys (2012 and 2008)
| Indication code |
Proportion of patients with each indication, %
|
|
|---|---|---|
| SAGE 2012 (n=1899) | SAGE 2008 (n=2263) | |
| 1: Severe or rapidly progressing dysphagia or odynophagia | 48 (2.5) | 44 (1.9) |
| 2: Stable dysphagia that is not severe | 67 (3.5) | 65 (2.9) |
| 3: Chronic GERD referred for screening endoscopy | 52 (2.7) | 60 (2.7) |
| 4: Poorly controlled reflux/dyspepsia, NO alarm symptoms | 145 (7.6) | 215 (9.5) |
| 5: Dyspepsia WITH alarm symptoms | 50 (2.6) | 67 (3.0) |
| 6: Confirmation of celiac disease antibody test | 20 (1.1) | 23 (1.0) |
| 7. Painless obstructive acute jaundice | 7 (0.4) | 10 (0.4) |
| 8: Persistent (>6 months) abnormal liver function tests | 61 (3.2) | 64 (2.8) |
| 9: Chronic viral hepatitis | 40 (2.1) | 38 (1.7) |
| 10: Chronic abdominal pain | 181 (9.5) | 205 (9.1) |
| 11: Clinical features of significant active IBD | 87 (4.6) | 128 (5.7) |
| 12: Chronic diarrhea or chronic constipation | 160 (8.4) | 229 (10.1) |
| 13: New-onset change in bowel habit | 68 (3.6) | 109 (4.8) |
| 14: Bright red rectal bleeding | 181 (9.5) | 209 (9.2) |
| 15: Documented iron deficiency anemia | 102 (5.4) | 132 (5.8) |
| 16: Fecal occult blood test positive | 65 (3.4) | 79 (3.5) |
| 17: Screening colonoscopy | 398 (21.0) | 438 (19.4) |
| 18: Cancer likely based on imaging or physical exam | 45 (2.4) | 65 (2.9) |
| OTHER | 122 (6.4) | – |
| Surveillance for previous colon cancer or polyps (20) | – | 56 (2.5) |
| Weight loss (21) | – | 8 (0.4) |
GERD Gastroesophageal reflux disease; IBD Inflammatory bowel disease; SAGE Survey of Access to GastroEnterology